IQV vs MEDP
Iqvia Holdings Inc. (IQV) and Medpace Holdings, Inc. (MEDP) are both filed with the SEC under Services-Commercial Physical & Biological Research. IQV is 2.6× MEDP's size by market cap ($43.8B against $17.1B); MEDP trades at the higher fiscal-year P/E (40.0× against 33.5×); MEDP reports the higher net margin (17.8% against 8.3%); MEDP grew sales faster over three years (+20.1% against +4.2%); and over the past year IQV returned +38.7% against MEDP's +27.0%.
| IQV | MEDP | |
|---|---|---|
| Last close | $261.75 | $600.65 |
| Market cap | $43.8B | $17.1B |
| P/E (FY) | 33.5× | 40.0× |
| P/S | 2.7× | 6.7× |
| EV/EBITDA | 17.3× | — |
| Operating margin | 13.4% | 21.1% |
| Net margin | 8.3% | 17.8% |
| Return on equity | 21.6% | 70.2% |
| Sales growth (3y) | +4.2% | +20.1% |
| EPS growth (3y) | +11.1% | +28.0% |
| 1-year return | +38.7% | +27.0% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year — FY2025 (ended 2025-12-31) for both. — not published for this company. A ratio goes unpublished for more than one reason: a component the calculation needs is not on file, the filing does not tag the line it is read from, or the calculation is not defined on the filed basis — EV/EBITDA is not printed on non-positive EBITDA, and return on equity is not computed on a zero or negative equity base.
Who holds them, and who has traded them
| IQV | MEDP | |
|---|---|---|
| Institutional holders (13F) | 1,062 | 726 |
| Insider buyers − sellers (180d) | — | -2 |
| Congressional trades disclosed (180d) | 1 | 2 |
| Executive-branch officials on file — trades disclosed (180d) | 8 | 0 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5. — no open-market Form 4 purchases or sales in the window.
IQV vs MEDP: common questions
- Is IQV bigger than MEDP?
- IQV carries the larger market cap — $43.8B against $17.1B, both struck on 2026-08-27.
- Which trades at a higher P/E, IQV or MEDP?
- MEDP, at a fiscal-year 40.0× against 33.5× for IQV. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have IQV and MEDP performed over the past year?
- IQV returned +38.7% and MEDP +27.0%, measured on the trailing calendar year to the last close.
- How many institutions hold IQV and MEDP?
- 1,062 13F filers report a position in IQV and 726 in MEDP, on the latest quarter in the panel.
- Are IQV and MEDP in the same industry?
- Both are filed with the SEC under Services-Commercial Physical & Biological Research, which is the classification this pairing is built on.
IQV overview → · MEDP overview → · IQV institutional ownership → · MEDP institutional ownership → · Congress and IQV → · Congress and MEDP → · Executive branch and IQV →
More in Services-Commercial Physical & Biological Research: INCY vs IQV · INCY vs MEDP
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/iqv-vs-medp